With respect to the investment project of Hong Kong Outjoy Education Technology Co., Ltd., a limited liability company registered in Hong Kong, and/or its designated investment companies (known as OET), In China Rapid Finance Limited, a limited liability company exempted from the Cayman Islands (the “company”), (such a transaction, the “transaction,” in accordance with the terms of the cooperation agreement, date of this agreement (effective date), by and between the Company and OET, oET proposes to acquire Class A common shares (by China Rapid Finance Limited (the “Company”), a par value of $0.0001 per share (the “common shares”), at a price per share equal to the purchase price (defined below), subject to the conditions shown here. In this context, OET and the Company agree that this share subscription agreement (the “contract” on the date [date contract] is entered into between [the seller`s name] (“seller”), a West Virginia [Corporation/Limited Liability Company] headquartered under [insert address] and [insert the full legal name of the shareholder] by [inserting the buyer`s address]] a west Virginia or West Virginia resident [Corporation/Limited Liability Company/Limited Liability Partnership/General Partnership/cooperative] (“Subscriber”). Whether you are a private investor or a company investing in another, a subscription contract describes the details of the transaction, including the price and agreed amount of the shares. If you are the investor, you can protect yourself from the fact that companies are changing the terms of the agreement. If your company sells shares or shares, you don`t want an investor to change their mind at the last minute. A subscription contract can help you turn a promise into a real transaction. A share purchase agreement is an agreement between a company and investors to sell shares at a fixed price to investors. This is done simply by offering new shares to investors who will become shareholders of the company at the close of the transaction. If a company wants to raise capital, it can do so by issuing shares that can be acquired through private placement or public offering.
CONSIDERING that any acquirer (or, if applicable, partner) is a shareholder in Guangzhou Miniso, a company linked to the PRC; and we are pleased to accept the offer of Big Cypress Holdings LLC (the subscriber or “you”) for the purchase of 2,156,250 common shares (the “shares”) with a face value of $0.0001 per share (the “Common Stock”), of which up to 281,250 of you expire fully or partially if the IPO insurers of Big Cypress Acquisition Corp., a Delaware company (the “Company”) do not fully exercise their over-allotment option (the over-allotment option). The terms (this “agreement”) to which the company is willing to: the shares to be sold to subscribers, and the agreements of the company and the subscriber regarding these shares are: The undersigned (“Subscriber”) subscribed below thirty million (30,000,000) shares of limited common shares (“shares”), $0.0001 per share (“Common Stock”), of PharmaCyte Biotech, Inc., a Nevada-based company, at a cash purchase price per share of $0.005 (“purchase price”).